THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL INFARCTION: WHERE ARE WE NOW? WHERE SHOULD WE GO?

被引:0
|
作者
HarveyDWhite
机构
[1] GreenLaneHospital
[2] Epsom!Auckland1003
[3] NewZealand
关键词
口引; In; TPA; 口口; WHERE ARE WE NOW; WHERE SHOULD WE GO; THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL INFARCTION;
D O I
暂无
中图分类号
R542.22 [];
学科分类号
1002 ; 100201 ;
摘要
The aim of treatment of acute myocardial infarction is to give aspirin and thrombolytic therapy as early as possible to as many patients as
引用
收藏
页码:64 / 67
页数:4
相关论文
共 50 条
  • [21] Behavioral Digital Therapeutics in Gastrointestinal Conditions Where Are We Now and Where Should We Go?
    Greywoode, Ruby
    Szigethy, Eva
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2022, 51 (04) : 741 - 752
  • [22] Twenty years of load theory—Where are we now, and where should we go next?
    Gillian Murphy
    John A. Groeger
    Ciara M. Greene
    Psychonomic Bulletin & Review, 2016, 23 : 1316 - 1340
  • [23] Content Analysis of Gender Roles in Media: Where Are We Now and Where Should We Go?
    Collins, Rebecca L.
    SEX ROLES, 2011, 64 (3-4) : 290 - 298
  • [24] Eating habits and behaviors of older people: Where are we now and where should we go?
    Yannakoulia, Mary
    Mamalaki, Eirini
    Anastasiou, Costas A.
    Mourtzi, Niki
    Lambrinoudaki, Irene
    Scarmeas, Nikolaos
    MATURITAS, 2018, 114 : 14 - 21
  • [25] Joint ESC/EASD Guidelines on Diabetes, where are we Now and where should we Go?
    Ryden, Lars
    Mellbin, Linda
    CURRENT VASCULAR PHARMACOLOGY, 2012, 10 (06) : 690 - 692
  • [26] Towards improved calibration of crop models - Where are we now and where should we go?
    Seidel, S. J.
    Palosuo, T.
    Thorburn, P.
    Wallach, D.
    EUROPEAN JOURNAL OF AGRONOMY, 2018, 94 : 25 - 35
  • [27] The clinical use of implantable cardioverter defibrillators: Where are we now? Where should we go?
    Buxton, AE
    ANNALS OF INTERNAL MEDICINE, 2003, 138 (06) : 512 - 514
  • [28] Nanosafety: Where Are We Now and Where Must We Go?
    Krug, Harald
    Kraegeloh, Annette
    CHEMICAL RESEARCH IN TOXICOLOGY, 2019, 32 (04) : 535 - 535
  • [29] Cell Therapy for Acute Myocardial Infarction—Where Do We Go From Here?
    Jay H. Traverse
    Timothy D. Henry
    Journal of Cardiovascular Translational Research, 2008, 1 : 64 - 70
  • [30] Biomarkers for Acute Kidney Injury: Where Are We Today? Where Should We Go?
    Lieske, John C.
    Chawla, Lakhmir
    Kashani, Kianoush
    Kellum, John A.
    Koyner, Jay L.
    Mehta, Ravindra L.
    CLINICAL CHEMISTRY, 2014, 60 (02) : 294 - 300